Preliminary evaluation of urinary polyamines in the diagnosis of genitourinary tract malignancy.
Normal ranges for urinary polyamines have been obtained. Non-malignant genitourinary tract disease is not associated with elevated urinary polyamines. A high correlation exists between the presence of active urologic cancer and elevated urinary excretion of polyamines. Post-treatment polyamines correlate with the continued presence or absence of genitourinary tract malignancy.
D000230:Adenocarcinoma / Q000175:diagnosis / Q000652:urine; D002295:Carcinoma, Transitional Cell / Q000175:diagnosis / Q000652:urine; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000652:urine; D008297:Male; D011073:Polyamines / Q000652:urine*; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000652:urine; D011700:Putrescine / Q000652:urine; D013096:Spermine / Q000652:urine; D013724:Teratoma / Q000175:diagnosis / Q000652:urine; D013736:Testicular Neoplasms / Q000175:diagnosis / Q000652:urine; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000652:urine; D014565:Urogenital Neoplasms / Q000175:diagnosis* / Q000652:urine; D014570:Urologic Diseases / Q000175:diagnosis / Q000652:urine
D011073:Polyamines; D013096:Spermine; D011700:Putrescine